Ohio State University, Columbus

-  It was noted that there was a significant increase in patients with additional comorbidities, asthma, and COVID-19 proportionately
- These comorbidities include, but were not limited to obesity, hypertension, sleep apnea, diabetes, etc.
- These values are presented in a more visual format in Figure 2


Discussion Regarding Additional Comorbidities of Patients with Asthma and COVID-19

Chhiba, K. D., Patel, G. B., Vu, T., Chen, M. M., Guo, A., Kudlaty, E., Mai, Q., Yeh, C., Muhammad, L. N., Harris, K. E., Bochner, B. S., Grammer, L. C., Greenberger, P. A., Kalhan, R., Kuang, F. L., Saltoun, C. A., Schleimer, R. P., Stevens, W. W., & Peters, A. T. (2020). Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. The Journal of allergy and clinical immunology, 146(2), 307–314.e4. https://doi.org/10.1016/j.jaci.2020.06.010

URL: https://pubmed.ncbi.nlm.nih.gov/32554082/

Learn Before

Related